Company intelligence / Profile preview

Biologos

Glendale Heights, Illinois, United Statesbiologos.org ↗

Ownership: Private
Employees: ~51
Development stage: Commercial

Overview

Biologos is an established GMP-compliant manufacturer of custom and standard cell culture media, reagents, buffers, enzymes, and sera. The company serves clients in cell & gene therapy, biopharma, diagnostics, tissue processing, animal health/vaccine development sectors. It operates from a state-of-the-art cGMP facility near Chicago and has shipped over 7 million liters of product globally[1][3][4]. In March 2024 it was acquired by Ampersand Capital Partners[3].

Modalities: Media and reagent manufacturing (not a therapeutic developer)Custom cell culture mediaBuffersSera
Industry: Chemicals & Materials

Beyond the preview

Go deeper on Biologos.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biologos.

Explore the full profile